QINGLI DOU

QINGLI DOU


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2024 in The Journal of nutrition, health and aging
Verified
Journal Article
Open access
XZXiaoming Zhang
Xiaoming Zhang
DYDongmei Ye
Dongmei Ye
RZRui Zeng
Rui Zeng
FXFayi Xie
Fayi Xie
WZWan Zhu
Wan Zhu
QDQINGLI DOU
QINGLI DOU

21 April 2022 in Frontiers in Pediatrics
Verified
Journal Article
Open access
XGXiu-Bing Gong
Xiu-Bing Gong
RFRui-Hua Feng
Rui-Hua Feng
HDHong-Mei Dong
Hong-Mei Dong
WLWen-Hua Liu
Wen-Hua Liu
YGYa-Nan Gu
Ya-Nan Gu
QDQINGLI DOU
QINGLI DOU
Background: Preclinical and clinical evidence suggests that hyperbaric oxygen therapy (HBOT) may benefit newborns. The effectiveness of HBOT for neonatal hypoxic-ischemic encephalopathy (HIE) remains controversial. We conducted a meta-analysis to evaluate the efficacy and prognosis of HBOT in neonates with HIE.Methods: A systematic search of eight databases was performed for available articles published between January 1, 2015, and September 30, 2020, to identify randomized controlled clinical trials (RCTs) on HBOT for neonatal HIE. Methodological quality assessment was performed by applying the simple procedure detailed by the Cochrane collaboration. Afterward, quality assessment and data analysis were performed using Revman 5.3 software. STATA 15 software was used to detect publication bias as well as for sensitivity analysis.Results: A total of 46 clinical RCTs were selected for the study and included 4,199 patients with neonatal HIE. The results indicated that HBOT significantly improved the total efficiency (TEF) of treatment for neonatal HIE patients [odds ratio (OR) = 4.61, 95% confidence interval (CI) (3.70, 5.75), P < 0.00001] and reduced the risk of sequelae (OR = 0.23, 95% CI (0.16, 0.33), P < 0.00001) and the neonatal behavioral neurological assessment (NBNA) scores [mean difference (MD) = 4.51, 95%CI (3.83,5.19, P < 0.00001)].Conclusion: In light of the effectiveness of HBOT neonatal HIE, this meta-analysis suggested that HBOT can be a potential therapy for the treatment of neonatal HIE. Due to the heterogeneity of studies protocol and patient selection being only from China, more research is needed before this therapy can be widely implemented in the clinic.Protocol Registration: PROSPERO (ID: CRD42020210639). Available online at: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020210639.

28 May 2025 in The Journal of nutrition, health and aging
Verified
Journal Article
Open access
XZXiaoming Zhang
Xiaoming Zhang
RZRui Zeng
Rui Zeng
AZAizhang Zhu
Aizhang Zhu
FXFayi Xie
Fayi Xie
DYDongmei Ye
Dongmei Ye
WZWenwu Zhang
Wenwu Zhang
Sensory impairment, including hearing and vision impairment, are prevalent in older adults and may significantly contribute to cognitive frailty. However, the longitudinal association between sensory impairment and cognitive frailty has not been fully explored. The aim of our study was to examine such associations in four nationally representative cohorts to inform strategies for preventing cognitive frailty and promoting healthy aging. Data were pooled from four large, longitudinal cohorts: the Health and Retirement Study (HRS), the Chinese Longitudinal Healthy Longevity Survey (CLHLS), the Survey of Health, Ageing and Retirement in Europe (SHARE), and the English Longitudinal Study of Ageing (ELSA). The analysis included 37,076 older adults from these cohorts, with comparable measures of sensory impairment and cognitive frailty across studies. Sensory impairments were assessed via self-reported hearing impairment and vision impairment. The outcome was the incidence of cognitive frailty, assessed using self-reported cognitive function and frailty indicators. Cox regression models were used to evaluate the association between hearing impairments, vision impairments and dual sensory impairment with cognitive frailty risk, adjusting for potential confounders. The cohort had a mean (SD) age of 74.60 (6.61) years for HRS (41.41% male), 81.87 (10.50) years for CLHLS (48.10% male), 72.99 (6.12) years for SHARE (44.27% male), and 73.03 (6.22) years for ELSA (46.59%% male). The prevalence of cognitive frailty was 10.58% for HRS, 6.26% for CLHLS, 12.16% for SHARE, and 5.81% for ELSA. The prevalence of dual sensory impairment was 8.05% for HRS, 3.06% for CLHLS, 10.94% for SHARE, and 4.06% for ELSA. Cox regression revealed a significant synergistic effect between hearing impairment and vision impairment on cognitive frailty risk. Compared to no sensory impairments individuals, those with hearing impairments or vision impairments had a higher risk of cognitive frailty across all cohorts, with individuals with dual sensory impairment exhibiting the highest risk: HRS (Hazard Ratio [HR] = 2.10, 95% CI, 1.71-2.56), CLHLS (HR = 2.08, 95% CI, 1.37-3.15), SHARE (HR = 1.52, 95% CI, 1.35-1.71), and ELSA (HR = 2.77, 95% CI, 1.78-4.31). This study identifies an association between combined hearing and vision impairments and an increased risk of cognitive frailty. These findings suggest that assessing sensory impairments, particularly dual sensory impairment, in older adults may help identify individuals at higher risk of cognitive frailty. Further research, including longitudinal studies and randomized controlled trials, is needed to explore the potential benefits of early sensory interventions for supporting healthy aging.

18 April 2025 in Aging Clinical and Experimental Research
Verified
Journal Article
Open access
PDF file
XZXiaoming Zhang
Xiaoming Zhang
RZRui Zeng
Rui Zeng
WZWenwu Zhang
Wenwu Zhang
FXFayi Xie
Fayi Xie
AZAizhang Zhu
Aizhang Zhu
CWConghua Wang
Conghua Wang
Purpose This study aimed to explore the association between sarcopenia, obesity, and sarcopenic obesity with depression in a middle-aged and elderly population in the United States. Methods We analyzed data from the National Health and Nutrition Examination Survey (NHANES) from 2005 to 2006 and from 2011 to 2018, including 5155 participants aged 45 years and older. Obesity was defined by a body mass index (BMI) ≥ 30 or waist circumference (WC) ≥ 102 cm in men or ≥ 88 cm in women. Sarcopenia was assessed using dual-energy X-ray absorptiometry (DXA) to calculate appendicular skeletal muscle mass index (ASMI), with gender-specific cut-offs. Multivariate logistic regression models adjusted for various covariates were used to assess the associations. Results Participants classified into the sarcopenia-only, obesity-only, and sarcopenic obesity groups exhibited multivariable-adjusted odds ratios (ORs) for depression of 1.35 (95% CI 0.60–2.18; P = 0.371), 1.37 (95% CI 1.03–1.82; P = 0.031), and 2.07 (95% CI 1.36–3.16; P < 0.001), respectively, compared to the robust group. Sensitivity analyses using alternative definitions of obesity and multiple imputation for missing data confirmed these findings. Subgroup analyses revealed that the association between sarcopenic obesity and depression was more pronounced in middle-aged women (aged ≤ 52 years). Conclusion This study underscores the significant relationship between sarcopenic obesity and depression in a large U.S. middle-aged and elderly population. Interventions focusing on weight control and muscle mass enhancement through proper nutrition and physical activity may reduce depression incidence, thereby promoting healthy aging.

3 June 2024 in The Journal of nutrition, health and aging
Verified
Journal Article
Open access
XZXiaoming Zhang
Xiaoming Zhang
LLLie-E Li
Lie-E Li
CWCong- Hua Wang
Cong- Hua Wang
QDQINGLI DOU
QINGLI DOU
YYYun- Zhi Yang
Yun- Zhi Yang

19 December 2025 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
YZYaWen Zheng
YaWen Zheng
CLCong Liu
Cong Liu
YLYaJun Li
YaJun Li
WWWenFei Wang
WenFei Wang
QDQINGLI DOU
QINGLI DOU
Inflammation serves as a fundamental defense against tissue injury and infection, yet dysregulation can lead to pathological outcomes. Thrombospondin-1 (Thbs1/TSP1), a multifunctional glycoprotein significantly upregulated during inflammation, exemplifies a dualistic regulator with context-dependent roles. Through modulation of cytokine networks and inflammatory cell activity (notably macrophages), Thbs1 critically governs inflammatory responses. Acute respiratory distress syndrome (ARDS), a life-threatening condition fueled by systemic inflammation secondary to infection or trauma, presents complex pathophysiology requiring elucidation. COVID-19 research highlights elevated Thbs1 expression in severe patients, where it demonstrates protective effects against pulmonary damage primarily via extracellular matrix protection, inhibition of neutrophil serine proteases, and TGF-β-dependent repair pathways. However, paradoxical evidence indicates that dysregulated Thbs1 can also contribute to ARDS pathogenesis, potentially by amplifying inflammation, promoting thromboinflammation, or driving fibrosis. Mechanistic insights reveal Thbs1’s influence on ARDS progression through ECM remodeling, serine protease inhibition, and TGF-β activation. While significant progress has been made in understanding Thbs1 signaling, the precise mechanisms dictating its context-dependent switch between protective and pathogenic functions in inflammatory pathways remain a critical area for future investigation.